GlassScriptPhysician profile
Manoj V Rao
NPI 1790946168
$35,590.37
in general payments reported to CMS, 2019-2025
60 companies · $3,403 in 2025
The $3,403 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,932 · 2020: $1,088 · 2021: $16K · 2022: $2,822 · 2023: $3,471 · 2024: $5,925 · 2025: $3,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,313 · Food and Beverage: $4,172 · Travel and Lodging: $279 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,312.50 |
| Food and Beverage | $4,171.89 |
| Travel and Lodging | $279.42 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $16,077.15 | 2020-2025 | Prolaris, Myrisk |
| Merck Sharp & Dohme LLC | $4,797.40 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Janssen Scientific Affairs, LLC | $3,511.92 | 2024 | Akeega |
| Neotract INC. | $2,131.60 | 2019 | |
| Pfizer INC. | $1,659.34 | 2019-2025 | |
| Janssen Biotech, INC. | $1,508.30 | 2019-2025 | Erleada, Akeega |
| Coloplast Corp | $470.98 | 2019-2025 | Titan, Virtue |
| Astellas Pharma US INC | $424.70 | 2019-2023 | Xtandi |
| Boston Scientific Corporation | $421.26 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Endo USA, INC. | $410.47 | 2024-2025 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $338.79 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $320.21 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $303.18 | 2023-2025 | Orgovyx, Gemtesa |
| Calyxo, INC. | $266.48 | 2022-2025 | Cvac Aspiration System |
| Olympus America INC. | $232.36 | 2020-2025 | Soltive, Itind System, Soltive |
Show all 59 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.